» Articles » PMID: 37738295

Perfluorooctanoic Acid Induces Transcriptomic Alterations in Second Trimester Human Cytotrophoblasts

Abstract

Poly- and perfluroroalkylated substances (PFAS) are a major class of surfactants used in industry applications and consumer products. Despite efforts to reduce the usage of PFAS due to their environmental persistence, compounds such as perfluorooctanoic acid (PFOA) are widely detected in human blood and tissue. Although growing evidence supports that prenatal exposures to PFOA and other PFAS are linked to adverse pregnancy outcomes, the target organs and pathways remain unclear. Recent investigations in mouse and human cell lines suggest that PFAS may impact the placenta and impair trophoblast function. In this study, we investigated the effects of PFOA on cytotoxicity and the transcriptome in cultured second trimester human cytotrophoblasts (CTBs). We show that PFOA significantly reduces viability and induces cell death at 24 h, in a concentration-dependent manner. At subcytotoxic concentrations, PFOA impacted expression of hundreds of genes, including several molecules (CRH, IFIT1, and TNFSF10) linked with lipid metabolism and innate immune response pathways. Furthermore, in silico analyses suggested that regulatory factors such as peroxisome proliferator-activated receptor-mediated pathways may be especially important in response to PFOA. In summary, this study provides evidence that PFOA alters primary human CTB viability and gene pathways that could contribute to placental dysfunction and disease.

Citing Articles

Exploring Toxicity of Per- and Polyfluoroalkyl Substances (PFAS) Mixture Through ADMET and Toxicogenomic In Silico Analysis: Molecular Insights.

Baralic K, Petkovski T, Piletic N, Maric D, Djordjevic A, Antonijevic B Int J Mol Sci. 2024; 25(22).

PMID: 39596398 PMC: 11594668. DOI: 10.3390/ijms252212333.


Per- and polyfluoroalkyl substances (PFAS) and hypertensive disorders of Pregnancy- integration of epidemiological and mechanistic evidence.

Dangudubiyyam S, Hofmann A, Yadav P, Kumar S Reprod Toxicol. 2024; 130:108702.

PMID: 39222887 PMC: 11625001. DOI: 10.1016/j.reprotox.2024.108702.

References
1.
Burleigh D, Kendziorski C, Choi Y, Grindle K, Grendell R, Magness R . Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta. 2006; 28(5-6):383-9. DOI: 10.1016/j.placenta.2006.05.001. View

2.
Tsang H, Cheung T, Kodithuwakku S, Chai J, Yeung W, Wong C . Perfluorooctanoate suppresses spheroid attachment on endometrial epithelial cells through peroxisome proliferator-activated receptor alpha and down-regulation of Wnt signaling. Reprod Toxicol. 2013; 42:164-71. DOI: 10.1016/j.reprotox.2013.08.001. View

3.
Szilagyi J, Freedman A, Kepper S, Keshava A, Bangma J, Fry R . Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro. Toxicol Sci. 2020; 175(2):210-219. PMC: 7253207. DOI: 10.1093/toxsci/kfaa043. View

4.
Perng W, Holzman C, Talge N, Senagore P . Placental pathology, corticotropin-releasing hormone, timing of parturition, and fetal growth in the pregnancy outcomes and community health study. J Matern Fetal Neonatal Med. 2018; 33(7):1225-1232. DOI: 10.1080/14767058.2018.1517318. View

5.
Fenton S, Ducatman A, Boobis A, DeWitt J, Lau C, Ng C . Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ Toxicol Chem. 2020; 40(3):606-630. PMC: 7906952. DOI: 10.1002/etc.4890. View